首页> 外文期刊>The clinical journal of pain >The efficacy of preoperative versus postoperative rofecoxib for preventing acute postoperative dental pain: a prospective randomized crossover study using bilateral symmetrical oral surgery.
【24h】

The efficacy of preoperative versus postoperative rofecoxib for preventing acute postoperative dental pain: a prospective randomized crossover study using bilateral symmetrical oral surgery.

机译:术前与术后罗非昔布预防急性术后牙痛的功效:一项使用双侧对称口腔手术的前瞻性随机交叉研究。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Previous data have demonstrated that rofecoxib has good analgesic efficacy for acute postoperative dental pain. However, up to half of these patients require rescue analgesics within the first 24 hours. As the timing of analgesic interventions may be an important factor in pain control, the present study tested the hypothesis that rofecoxib administered preoperatively would improve the analgesic efficacy and reduce rescue analgesic requirements within the first 24 hours compared with postoperative administration. METHODS: This was a double-blind, randomized, crossover study where 45 patients had each of their identical impacted mandibular third molars removed under local anesthesia on 2 separate occasions. Patients acted as their own control; one side was pretreated with rofecoxib 50 mg, 2 hours before surgery, followed by placebo 15 minutes after surgery, and the contralateral side was pretreated with placebo 2 hours before surgery and posttreated with rofecoxib 50 mg 15 minutes after surgery. The difference in postoperative pain between 2 sides was assessed by 4 primary end-points: pain intensity as measured by a 100-mm visual analogue scale hourly for 12 hours, time to rescue analgesic, postoperative analgesic consumption, and patient's global assessment. RESULTS: Patients reported significantly lower pain scores (P = 0.04), longer time to rescue analgesic (P = 0.02), lesser postoperative analgesic consumption (P = 0.008), and better global assessment (P = 0.01) in the pretreated compared with the posttreated sides. There were significantly more patients in the pretreated group who did not required rescue analgesic within the first 24 hours (80% vs. 58%, P = 0.01), and the pain scores were extremely low in both groups during the 12 hours postoperative period (9.8 +/- 5.0 mm vs. 14.3 +/- 7.4 mm). CONCLUSION: Rofecoxib is an excellent analgesic for preventing postoperative dental pain and when given 2 hours preoperatively rendered most patients relatively pain free, requiring no rescue analgesics on the first postoperative day.
机译:背景:以前的数据表明罗非昔布对急性术后牙痛具有良好的镇痛作用。但是,这些患者中有多达一半在最初的24小时内需要抢救镇痛药。由于镇痛措施的时机可能是控制疼痛的重要因素,因此本研究检验了以下假设:与术后给药相比,术前服用罗非昔布将在术后24小时内提高镇痛效果并降低急救镇痛要求。方法:这是一项双盲,随机,交叉研究,其中45例患者在局部麻醉下分别两次将各自相同的下颌第三磨牙进行了局部麻醉。患者作为自己的对照;一侧在手术前2小时用罗非考昔50 mg进行预处理,然后在手术后15分钟进行安慰剂的治疗,对侧在手术前2小时用安慰剂进行预处理,并在手术后15分钟用罗非考昔50 mg进行后处理。通过4个主要终点来评估两侧之间的术后疼痛差异:通过每小时100毫米视觉模拟量表测量持续12小时的疼痛强度,抢救止痛药的时间,术后止痛药的消耗以及患者的总体评估。结果:与常规治疗相比,患者报告的疼痛评分(P = 0.04)明显降低,挽救镇痛的时间更长(P = 0.02),术后镇痛药的消耗更少(P = 0.008),整体评估更好(P = 0.01)。后处理的侧面。预处理组中有显着更多的患者在开始的24小时内不需要急救镇痛(80%比58%,P = 0.01),并且两组术后12小时的疼痛评分极低( 9.8 +/- 5.0毫米和14.3 +/- 7.4毫米)。结论:罗非昔布是预防术后牙痛的极佳止痛药,术前2小时给予大多数患者相对无痛,术后第一天无需急救止痛药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号